Medications for alpha-1-antitrypsin deficiency are used to treat emphysema that's caused by this genetic disorder. They're not intended to treat lung conditions in people without alpha-1-antitrypsin deficiency. They work by supplementing the body with alpha-1-antitrypsin protein to protect the lungs from damage. These medications belong to the human alpha1-proteinase inhibitor class of medications. Examples of medications in this class include Aralast NP (alpha1-proteinase inhibitor), Glassia (alpha1-proteinase inhibitor), and Prolastin C (alpha1-proteinase inhibitor). These medications are typically administered as injectable solutions, providing a direct way to increase your alpha-1-antitrypsin levels and help protect your lungs.
